Skip to main content
TipRanks
Go Ultimate75% OFF

Santhera Pharmaceuticals Holding (SANN) Ratios

6 Followers

Santhera Pharmaceuticals Holding Ratios

CH:SANN's free cash flow for Q2 2026 was CHF14.79M. For the 2026 fiscal year, CH:SANN's free cash flow was decreased by CHF-38.00K and operating cash flow was CHF14.82M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Dec 23Mar 23Dec 21
Liquidity Ratios
Current Ratio1.291.640.780.060.75
Quick Ratio0.891.260.740.060.74
Cash Ratio0.360.890.690.030.65
Solvency Ratio-0.27-0.291.16-0.63-0.58
Operating Cash Flow Ratio-0.56-0.771.07-0.60-1.14
Short-Term Operating Cash Flow Coverage-2.44-5.112.26-1.35-2.43
Net Current Asset ValueCHF -79.66MCHF -48.98MCHF -15.03MCHF -104.35MCHF -65.15M
Leverage Ratios
Debt-to-Assets Ratio0.660.270.210.700.47
Debt-to-Equity Ratio-8.271.490.38-1.0232.36
Debt-to-Capital Ratio1.140.600.2859.170.97
Long-Term Debt-to-Capital Ratio1.190.530.02-0.930.95
Financial Leverage Ratio-12.535.511.83-1.4668.61
Debt Service Coverage Ratio-1.25-0.601.87-1.12-1.11
Interest Coverage Ratio-3.27-1.663.23-2.57-3.46
Debt to Market Cap0.530.250.220.510.91
Interest Debt Per Share8.405.394.1910.6117.38
Net Debt to EBITDA-2.34-0.02-0.09-0.92-0.63
Profitability Margins
Gross Profit Margin18.74%58.69%96.87%51.93%336.18%
EBIT Margin-48.99%-55.05%73.62%-674.79%2400.88%
EBITDA Margin-41.62%-40.62%76.56%-625.97%2167.40%
Operating Profit Margin-48.99%-85.34%66.57%-695.52%3566.65%
Pretax Profit Margin-63.55%-106.51%53.01%-944.95%3430.53%
Net Profit Margin-63.79%-107.30%52.97%-951.10%3481.25%
Continuous Operations Profit Margin-63.79%-107.30%52.97%-951.10%3481.25%
Net Income Per EBT100.38%100.75%99.93%100.65%101.48%
EBT Per EBIT129.71%124.80%79.63%135.86%96.18%
Return on Assets (ROA)-33.25%-27.53%49.97%-111.53%-60.94%
Return on Equity (ROE)416.69%-151.54%91.39%162.70%-4181.17%
Return on Capital Employed (ROCE)-44.02%-31.39%105.40%-363.16%-97.52%
Return on Invested Capital (ROIC)-37.53%-29.32%79.23%-140.24%-76.55%
Return on Tangible Assets-58.51%-50.24%153.61%-1572.48%-209.37%
Earnings Yield-30.02%-26.70%52.79%-84.53%-122.18%
Efficiency Ratios
Receivables Turnover2.962.82235.036.85-0.82
Payables Turnover4.621.680.910.921.56
Inventory Turnover2.520.891.7933.268.80
Fixed Asset Turnover38.4015.21177.697.41-1.20
Asset Turnover0.520.260.940.12-0.02
Working Capital Turnover Ratio3.233.91-3.69-0.270.16
Cash Conversion Cycle188.81324.65-195.33-331.53-635.27
Days of Sales Outstanding123.13129.561.5553.29-443.03
Days of Inventory Outstanding144.72411.83204.3310.9741.47
Days of Payables Outstanding79.05216.73401.22395.79233.71
Operating Cycle267.85541.39205.8964.26-401.56
Cash Flow Ratios
Operating Cash Flow Per Share-2.67-3.124.47-4.90-10.93
Free Cash Flow Per Share-2.68-3.142.22-5.55-10.94
Dividend Paid and CapEx Coverage Ratio-668.52-235.281.99-7.54-2490.60
Capital Expenditure Coverage Ratio-668.52-235.281.99-7.54-2490.60
Operating Cash Flow Coverage Ratio-0.36-0.862.05-0.67-0.87
Operating Cash Flow to Sales Ratio-0.45-0.910.46-3.9923.42
Free Cash Flow Yield-21.23%-22.70%22.67%-40.20%-82.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.33-3.751.89-1.18-0.82
Price-to-Sales (P/S) Ratio2.124.021.0011.25-28.49
Price-to-Book (P/B) Ratio-13.885.681.73-1.9234.22
Price-to-Free Cash Flow (P/FCF) Ratio-4.71-4.414.41-2.49-1.22
Price-to-Operating Cash Flow Ratio-4.72-4.422.20-2.82-1.22
Price-to-Earnings Growth (PEG) Ratio-1.370.02-0.010.040.01
Enterprise Value Multiple-7.45-9.911.22-2.72-1.94
Enterprise Value239.31M157.45M96.43M127.16M67.21M
EV to EBITDA-7.45-9.911.22-2.72-1.94
EV to Sales3.104.030.9317.02-42.14
EV to Free Cash Flow-6.87-4.414.10-3.76-1.80
EV to Operating Cash Flow-6.88-4.432.04-4.26-1.80
Tangible Book Value Per Share-5.82-3.63-1.33-16.89-18.52
Shareholders’ Equity Per Share-0.912.435.67-7.170.39
Tax and Other Ratios
Effective Tax Rate-0.00-0.010.00-0.01-0.01
Revenue Per Share5.933.449.781.23-0.47
Net Income Per Share-3.78-3.695.18-11.67-16.25
Tax Burden1.001.011.001.011.01
Interest Burden1.301.930.721.401.43
Research & Development to Revenue0.290.680.184.09-18.63
SG&A to Revenue0.400.760.201.95-7.98
Stock-Based Compensation to Revenue0.000.000.060.73-1.73
Income Quality0.710.850.860.420.68

Currency in CHF